Release of our first CSR Report!
We’re excited to announce the publication of our first CSR Report!
As part of the agreement, HTL will build, validate and operate a botulinum manufacturing facility in the US. In the future, HTL Biotechnology expects to apply to the CDC to have the facility certified to manufacture botulinum and later apply to the FDA to have it certified as a GMP plant.
Read more below.
HTL Biotechnology made a strong impact this year at IMCAS with a reinforced presence and exciting interactions with our customers and partners.
We’re happy to share that HTL Biotechnology got the new certification ISO 13485.
We’re excited to announce the publication of our first CSR Report!